These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11882749)

  • 1. How many patients complete an adequate trial of donepezil?
    Roe CM; Anderson MJ; Spivack B
    Alzheimer Dis Assoc Disord; 2002; 16(1):49-51. PubMed ID: 11882749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil and athetosis in an elderly patient with Alzheimer's disease.
    Tanaka M; Yokode M; Kita T; Matsubayashi K
    J Am Geriatr Soc; 2003 Jun; 51(6):889-90. PubMed ID: 12757588
    [No Abstract]   [Full Text] [Related]  

  • 3. Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?
    Bullock R; Connolly C
    Int J Geriatr Psychiatry; 2002 Mar; 17(3):288-9. PubMed ID: 11921158
    [No Abstract]   [Full Text] [Related]  

  • 4. Unsafe prescription medication switching recommendations.
    Subbiah P; Schwam EM
    Clin Ther; 2001 Dec; 23(12):2050-5. PubMed ID: 11813938
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary incontinence: an unrecognised adverse effect with donepezil.
    Hashimoto M; Imamura T; Tanimukai S; Kazui H; Mori E
    Lancet; 2000 Aug; 356(9229):568. PubMed ID: 10950240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain injury, cognitive impairment, and donepezil.
    Whitlock JA
    J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced lupus erythematosus associated with donepezil: a case report.
    Manzo C; Putignano S
    Age Ageing; 2015 Nov; 44(6):1062-3. PubMed ID: 26420637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil-induced nightmares in mild cognitive impairment.
    Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
    Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R;
    Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the FDA forgot the evidence: the case of donepezil 23 mg.
    Schwartz LM; Woloshin S
    BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease.
    Cummings JL; Donohue JA; Brooks RL
    Am J Geriatr Psychiatry; 2000; 8(2):134-40. PubMed ID: 10804074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donepezil therapy for neuropsychiatric symptoms in AD: methods make the message.
    Herrmann N; Knopman D
    Neurology; 2004 Jul; 63(2):200-1. PubMed ID: 15277606
    [No Abstract]   [Full Text] [Related]  

  • 13. Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
    Matthews HP; Korbey J; Wilkinson DG; Rowden J
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):713-20. PubMed ID: 10960883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial results for donepezil in Alzheimer's disease: is the treatment glass half full or half empty?
    Farlow MR
    J Am Geriatr Soc; 2008 Aug; 56(8):1566-7. PubMed ID: 18808602
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to "Results, rhetoric, and randomized trials: the case of donepezil".
    Lisi D
    J Am Geriatr Soc; 2009 Jul; 57(7):1317-8; author reply 1318. PubMed ID: 19570171
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mania associated with donepezil.
    Benazzi F
    Int J Geriatr Psychiatry; 1998 Nov; 13(11):814-5. PubMed ID: 9850879
    [No Abstract]   [Full Text] [Related]  

  • 18. Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial.
    Crane PK; Doody RS
    Neurology; 2009 Nov; 73(18):1514-5; author reply 1515-6. PubMed ID: 19884584
    [No Abstract]   [Full Text] [Related]  

  • 19. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical benefits of a new piperidine-class AChE inhibitor.
    Doody RS
    Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S69-77. PubMed ID: 10332937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.